Treatment of disfiguring chronic graft versus host disease in a child with topical pimecrolimus

Pediatr Int. 2010 Jun;52(3):e161-3. doi: 10.1111/j.1442-200X.2010.03078.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Bone Marrow Transplantation / adverse effects*
  • Bone Marrow Transplantation / methods
  • Chemotherapy, Adjuvant
  • Child
  • Chronic Disease
  • Combined Modality Therapy
  • Dermatitis, Seborrheic / drug therapy*
  • Dermatitis, Seborrheic / etiology
  • Dermatitis, Seborrheic / pathology
  • Dermatologic Agents / therapeutic use
  • Follow-Up Studies
  • Graft vs Host Disease / complications
  • Graft vs Host Disease / diagnosis
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Male
  • Radiotherapy, Adjuvant
  • Severity of Illness Index
  • Tacrolimus / analogs & derivatives*
  • Tacrolimus / therapeutic use
  • Treatment Outcome
  • beta-Thalassemia / diagnosis
  • beta-Thalassemia / therapy*

Substances

  • Dermatologic Agents
  • pimecrolimus
  • Tacrolimus